Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
370M
-
Number of holders
-
145
-
Total 13F shares, excl. options
-
82.1M
-
Shares change
-
+1.88M
-
Total reported value, excl. options
-
$117M
-
Value change
-
+$2.65M
-
Put/Call ratio
-
1.96
-
Number of buys
-
68
-
Number of sells
-
-45
-
Price
-
$1.42
Significant Holders of PRECIGEN, INC. - Common Stock (PGEN) as of Q2 2025
168 filings reported holding PGEN - PRECIGEN, INC. - Common Stock as of Q2 2025.
PRECIGEN, INC. - Common Stock (PGEN) has 145 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 82.1M shares
of 370M outstanding shares and own 22.17% of the company stock.
Largest 10 shareholders include Patient Capital Management, LLC (16.3M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (11.3M shares), BlackRock, Inc. (11.1M shares), VANGUARD GROUP INC (9.07M shares), IRIDIAN ASSET MANAGEMENT LLC/CT (4.28M shares), GEODE CAPITAL MANAGEMENT, LLC (3.75M shares), STATE STREET CORP (3.03M shares), MORGAN STANLEY (2.04M shares), Parkman Healthcare Partners LLC (1.54M shares), and Schonfeld Strategic Advisors LLC (1.44M shares).
This table shows the top 145 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.